161 related articles for article (PubMed ID: 23730526)
1. Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
Kashfi K
For Immunopathol Dis Therap; 2012; 3(2):97-108. PubMed ID: 23730526
[TBL] [Abstract][Full Text] [Related]
2. NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
Chattopadhyay M; Goswami S; Rodes DB; Kodela R; Velazquez CA; Boring D; Crowell JA; Kashfi K
Cancer Lett; 2010 Dec; 298(2):204-11. PubMed ID: 20674154
[TBL] [Abstract][Full Text] [Related]
3. JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.
Nath N; Chattopadhyay M; Pospishil L; Cieciura LZ; Goswami S; Kodela R; Saavedra JE; Keefer LK; Kashfi K
Biochem Pharmacol; 2010 Dec; 80(11):1641-9. PubMed ID: 20797387
[TBL] [Abstract][Full Text] [Related]
4. Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.
Williams JL; Ji P; Ouyang N; Kopelovich L; Rigas B
Exp Cell Res; 2011 Jun; 317(10):1359-67. PubMed ID: 21406194
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.
Greenspan EJ; Madigan JP; Boardman LA; Rosenberg DW
Cancer Prev Res (Phila); 2011 Jan; 4(1):161-71. PubMed ID: 21205744
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
7. Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets β-catenin.
Nath N; Liu X; Jacobs L; Kashfi K
Drug Des Devel Ther; 2013; 7():389-96. PubMed ID: 23690679
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion.
Cheng H; Mollica MY; Lee SH; Wang L; Velázquez-Martínez CA; Wu S
Toxicol Appl Pharmacol; 2012 Oct; 264(2):161-6. PubMed ID: 22889880
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
Liu L; Huang Z; Chen J; Wang J; Wang S
J Exp Clin Cancer Res; 2018 Jul; 37(1):142. PubMed ID: 29986744
[TBL] [Abstract][Full Text] [Related]
10. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.
Paul S; DeCastro AJ; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Zhou R; Rimando AM; Suh N
Carcinogenesis; 2010 Jul; 31(7):1272-8. PubMed ID: 20061362
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B
Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512
[TBL] [Abstract][Full Text] [Related]
12. NOS2 regulation of NF-kappaB by S-nitrosylation of p65.
Kelleher ZT; Matsumoto A; Stamler JS; Marshall HE
J Biol Chem; 2007 Oct; 282(42):30667-72. PubMed ID: 17720813
[TBL] [Abstract][Full Text] [Related]
13. Colon cancer prevention with NO-releasing NSAIDs.
Kaza CS; Kashfi K; Rigas B
Prostaglandins Other Lipid Mediat; 2002 Feb; 67(2):107-20. PubMed ID: 11936617
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
15. iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53.
Nakazawa H; Chang K; Shinozaki S; Yasukawa T; Ishimaru K; Yasuhara S; Yu YM; Martyn JA; Tompkins RG; Shimokado K; Kaneki M
PLoS One; 2017; 12(1):e0170391. PubMed ID: 28099528
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of S-nitrosylated Golgi proteins: new insights into endothelial cell regulation by eNOS-derived NO.
Sangwung P; Greco TM; Wang Y; Ischiropoulos H; Sessa WC; Iwakiri Y
PLoS One; 2012; 7(2):e31564. PubMed ID: 22363674
[TBL] [Abstract][Full Text] [Related]
17. Nitric-oxide-donating NSAIDs as agents for cancer prevention.
Rigas B; Kashfi K
Trends Mol Med; 2004 Jul; 10(7):324-30. PubMed ID: 15242680
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells.
Park GH; Song HM; Park SB; Son HJ; Um Y; Kim HS; Jeong JB
BMC Complement Altern Med; 2018 Jan; 18(1):28. PubMed ID: 29554905
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory agents as cancer therapeutics.
Kashfi K
Adv Pharmacol; 2009; 57():31-89. PubMed ID: 20230759
[TBL] [Abstract][Full Text] [Related]
20. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
